Literature DB >> 23479462

Freedom and rules in human sequential performance: a refractory period in eye-hand coordination.

Diego E Shalom1, Mariano Sigman.   

Abstract

In action sequences, the eyes and hands ought to be coordinated in precise ways. The mechanisms governing the architecture of encoding and action of several effectors remain unknown. Here we study hand and eye movements in a sequential task in which letters have to be typed while they move down through the screen. We observe a strict refractory period of about 200 ms between the initiation of manual and eye movements. Subjects do not initiate a saccade just after typing and do not type just after making the saccade. This refractory period is observed ubiquitously in every subject and in each step of the sequential task, even when keystrokes and saccades correspond to different items of the sequence-for instance when a subject types a letter that has been gazed at in a preceding fixation. These results extend classic findings of dual-task paradigms, of a bottleneck tightly locked to the response selection process, to unbounded serial routines. Interestingly, while the bottleneck is seemingly inevitable, better performing subjects can adopt a strategy to minimize the cost of the bottleneck, overlapping the refractory period with the encoding of the next item in the sequence.

Entities:  

Mesh:

Year:  2013        PMID: 23479462     DOI: 10.1167/13.3.4

Source DB:  PubMed          Journal:  J Vis        ISSN: 1534-7362            Impact factor:   2.240


  2 in total

1.  Quantifying gaze and mouse interactions on spatial visual interfaces with a new movement analytics methodology.

Authors:  Urška Demšar; Arzu Çöltekin
Journal:  PLoS One       Date:  2017-08-04       Impact factor: 3.240

2.  Unveiling Trail Making Test: visual and manual trajectories indexing multiple executive processes.

Authors:  Ignacio Linari; Gustavo E Juantorena; Agustín Ibáñez; Agustín Petroni; Juan E Kamienkowski
Journal:  Sci Rep       Date:  2022-08-22       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.